216 related articles for article (PubMed ID: 8799409)
1. Effect of percutaneous ethanol injection for postoperative recurrence of hepatocellular carcinoma in combination with transcatheter arterial embolization.
Ishii H; Okada S; Sato T; Nose H; Okusaka T; Yoshimori M; Takayasu K; Takayama T; Kosuge T; Yamasaki S
Hepatogastroenterology; 1996; 43(9):644-50. PubMed ID: 8799409
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with transcatheter arterial embolization and percutaneous ethanol injection for advanced hepatocellular carcinoma.
Koda M; Okamoto K; Miyoshi Y; Kato S; Murawaki Y; Horie Y; Suou T; Kawasaki H
Hepatogastroenterology; 1994 Feb; 41(1):25-9. PubMed ID: 8175109
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy for large hepatocellular carcinoma combined with transcatheter arterial embolization and percutaneous ethanol injection therapy.
Yasuda S; Ito H; Yoshikawa M; Shinozaki M; Goto N; Fujimoto H; Nasu K; Uno T; Itami J; Isobe K; Shigematsu N; Ebara M; Saisho H
Int J Oncol; 1999 Sep; 15(3):467-73. PubMed ID: 10427126
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for recurrence of large HCC in patients treated by combined TAE and PEI.
Arata S; Tanaka K; Okazaki H; Kondo M; Morimoto M; Saito S; Numata K; Nakamura S; Sekihara H
Hepatogastroenterology; 2001; 48(38):480-5. PubMed ID: 11379338
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis and treatment for recurrent hepatocellular carcinoma].
Yoshikawa M; Ebara M; Fukuda H; Sugiura N; Saisho H
Gan To Kagaku Ryoho; 1998 Feb; 25(3):327-32. PubMed ID: 9492824
[TBL] [Abstract][Full Text] [Related]
7. Combination of transcatheter arterial embolization and percutaneous ethanol injection for hepatocellular carcinoma: comparison of efficacies of doxorubicin and epirubicin in transcatheter arterial embolization.
Nakamura S; Tanaka K
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-46-S6-49. PubMed ID: 9151916
[TBL] [Abstract][Full Text] [Related]
8. Multimodality treatment for patients with hepatocellular carcinoma: a single institution retrospective series.
Takano S; Watanabe Y; Ohishi H; Kono S; Nakamura M; Kubota N; Iwai S
Eur J Surg Oncol; 2000 Feb; 26(1):67-72. PubMed ID: 10718183
[TBL] [Abstract][Full Text] [Related]
9. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
Suzuki M; Suzuki H; Yamamoto T; Mamada Y; Mizuno H; Tominaga T; Suga M; Suemori S; Kato Y; Sato A; Yamanouchi E; Sakuyama K; Maeyama S; Shinagawa T; Okabe K
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.
Ueno S; Tanabe G; Nuruki K; Oketani M; Komorizono Y; Hokotate H; Fukukura Y; Baba Y; Imamura Y; Aikou T
J Hepatobiliary Pancreat Surg; 2002; 9(4):469-77. PubMed ID: 12483269
[TBL] [Abstract][Full Text] [Related]
11. The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy.
Kotoh K; Sakai H; Sakamoto S; Nakayama S; Satoh M; Morotomi I; Nawata H
Am J Gastroenterol; 1994 Feb; 89(2):194-8. PubMed ID: 8304302
[TBL] [Abstract][Full Text] [Related]
12. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
[TBL] [Abstract][Full Text] [Related]
13. [Radiofrequency ablation and percutaneous ethanol injection in patients with unresectable hepatocellular carcinoma--a comparative study using Japan Integrated Staging Score (JIS score) system].
Morimoto M; Numata K; Sugimori K; Shirato K; Kokawa A; Oka H; Hirao M; Hirasawa K; Ko R; Saitou T; Imada T; Tanaka K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1592-5. PubMed ID: 16315880
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in resected hepatocellular carcinomas and therapeutic value of transcatheter arterial embolization for recurrences.
Kimura H; Yabushita K; Konishi K; Maeda K; Kuroda Y; Tsuji M; Demachi H; Miwa A
Int Surg; 1998; 83(2):146-9. PubMed ID: 9851333
[TBL] [Abstract][Full Text] [Related]
15. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
[TBL] [Abstract][Full Text] [Related]
16. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma.
Peng ZW; Zhang YJ; Chen MS; Liang HH; Li JQ; Zhang YQ; Lau WY
Surg Oncol; 2008 Jul; 17(1):23-31. PubMed ID: 17869095
[TBL] [Abstract][Full Text] [Related]
17. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
Chen XM; Luo PF; Lin HH; Zhou ZJ; Shao PJ; Fu L; Li WK
Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of transcatheter arterial embolization therapy for small hepatocellular carcinomas: comparison with other treatments.
Arai K; Matsui O; Takashima T; Kadoya M; Yoshikawa J; Gabata T; Ueda K; Kawamori Y; Izumi R; Kobayashi K
Radiat Med; 1990; 8(5):191-8. PubMed ID: 1963696
[TBL] [Abstract][Full Text] [Related]
19. [Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection].
Ge NL; Ren ZG; Ye SL; Lin ZY; Xia JL; Gan YH; Li LX; Shen YF; Tang ZY
Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):380-2. PubMed ID: 16117905
[TBL] [Abstract][Full Text] [Related]
20. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
